Matisse Capital Johnson & Johnson Transaction History
Matisse Capital
- $205 Million
- Q1 2024
A detailed history of Matisse Capital transactions in Johnson & Johnson stock. As of the latest transaction made, Matisse Capital holds 1,865 shares of JNJ stock, worth $272,588. This represents 0.14% of its overall portfolio holdings.
Number of Shares
1,865
Previous 1,880
0.8%
Holding current value
$272,588
Previous $294,000
0.34%
% of portfolio
0.14%
Previous 0.16%
Shares
10 transactions
Others Institutions Holding JNJ
# of Institutions
4,145Shares Held
1.64BCall Options Held
15.1MPut Options Held
12.1M-
Vanguard Group Inc Valley Forge, PA229MShares$33.5 Billion0.73% of portfolio
-
Black Rock Inc. New York, NY190MShares$27.7 Billion0.71% of portfolio
-
State Street Corp Boston, MA134MShares$19.5 Billion0.96% of portfolio
-
Geode Capital Management, LLC Boston, MA53.3MShares$7.79 Billion0.79% of portfolio
-
Morgan Stanley New York, NY42.5MShares$6.22 Billion0.55% of portfolio
About JOHNSON & JOHNSON
- Ticker JNJ
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,614,479,872
- Market Cap $382B
- Description
- Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...